Lexicon Pharma (LXRX) Reports Topline Results From Phase 2 P

Lexicon Pharma (LXRX) Reports Topline Results From Phase 2 Proof-of-Concept Study of LX9211

Lexicon Pharma (LXRX) Reports Topline Results From Phase 2 Proof-of-Concept Study of LX9211
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

, Craig Granowitz , Bristol Myers Squibb , Exchange Commission , Alina Kolomeyerlexicon Pharmaceuticals Inc , Lexicon Pharmaceuticals , Drug Administration , Carrie Siragusalexicon Pharmaceuticals Inc , Nasdaq , Lexicon Pharmaceuticals Inc , Fast Track , Live Conference Call , Average Daily Pain Score , Investor Inquiries , Siragusalexicon Pharmaceuticals , Media Inquiries , Kolomeyerlexicon Pharmaceuticals , Placebo Was Seen , Mean Change ,